Phase II immunology clinical trial starts growth rate
Global, 2024–2025 to 2025
14%
2025
Phase II immunology clinical trial starts growth rate: Global, 2024–2025 to 2025
Phase II immunology clinical trial starts growth rate: Global, 2024–2025 to 2025. 2 observations from 2024–2025 to 2025, ranging from 14% to 14%. Latest value 14% (2025).
%
0
3
6
9
12
15
2024
2025
14%
14%
Phase II immunology clinical trial starts growth rate: Global, 2024–2025 to 2025
Phase II immunology clinical trial starts growth rate: Global, 2024–2025 to 2025. 2 observations from 2024–2025 to 2025, ranging from 14% to 14%. Latest value 14% (2025).
%
0
5
10
15
2024
2025
14%
14%
Phase II immunology clinical trial starts growth rate: Global, 2024–2025 to 2025
Phase II immunology clinical trial starts growth rate: Global, 2024–2025 to 2025. 2 observations from 2024–2025 to 2025, ranging from 14% to 14%. Latest value 14% (2025).
%
0
5
10
15
2024
2025
14%
14%
View the underlying data
Phase II immunology clinical trial starts growth rate: Global, 2024–2025 to 2025
Period
Type
Value
2024–2025
Actual
14%
2025
Actual
14%
Chart:
StatOrigin
· Source: IQVIA ·
statorigin.org
CC BY 4.0